IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Glenda Korporaal

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

October 27, 2024
IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.
Read Transcript

While the performance of the small cap sector in Australia has been mixed in recent years, IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks in Australia, including in the consumer sector.

“It’s been a tough couple of years for small caps, but this might be the year for them,” said Bannan, a small cap specialist at the $220bn industry super backed IFM Investors.

“Mispriced opportunities tend to be more prevalent in the small cap sector. It could be a good time to be investing in the space.”

Bannan, whose stock tip at the last Sohn Australia conference last November – ASX-listed bio tech company Telix Pharmaceuticals – has more than doubled in price over the year, will be tipping another small cap when she speaks at this year’s Sohn conference in Adelaide on November 15.

But with Sohn attendees paying $3500 a head for tickets to the conference, she is tight-lipped about what sector it might be in.

There are some hints she likes some stocks in the consumer sector, with some companies performing better than expected and this year’s tax rate cuts and expected falls in interest rates over the next year ease pressure on consumers.

“The consumer sector – whether it is retail, consumer services, media, or travel – has been quite topical recently,” she said.

“It has been a tough consumer environment in the last couple of years given the cost-of-living pressures and high interest rates.

“(But) a lot of stocks have performed better than expected and declines in same-store sales have not been as severe.”

Bannan says some retailers have done a good job managing their costs, including managing inventory, “which means gross margins have held up well”.

“With the focus turning to rate cuts and the tax cuts which kicked in in June, there is a sense that the consumer could be through the worst of it,” she said.

“It is still a tough environment, but … there could be potentially some good opportunities there.”

IFM, which has $65bn in shares, manages funds for industry super funds in Australia as well as institutional investors offshore, and does not publish a list of its holdings.

Bannan says IFM’s small cap holdings range from companies in mining, health care and tech to the consumer sector. But even within sectors, she says, there are very different companies with very different growth potential.

“Across any sector we are looking for the structural growth story,” she said. “We are very bottom up focused.

IFM prefers companies that can grow despite the prevailing macro economic conditions, she adds. “We are looking for businesses with a sustainable competitive advantage. There is a big focus on the quality of management, understanding their strategy and how they are going to execute it, how they plan to fund it.

“We look at the cash generation of the business.”

Bannan says IFM also has a strong interest in “founder-led businesses”. “We like management to be aligned with shareholders.”

While Bannan is still a fan of Telix, which she believes still has significant potential in the growing area of cancer diagnostics, she will be tipping a very different stock this year. She has a strong interest in healthcare stocks and is on the advisory committee of HEAL Partners, a growth private equity fund focused on investments within the health, education and lifestyle sectors.

Bannan says she has had an interest in supporting the Sohn conference which raises money for medical research as one of her closest friends died of cancer at the age of 34. She jumped at the chance to participate in the conference last year and the success of her stock pick in 2023 has seen her invited back again.

Co-founders of the conference in Australia have included former UBS chief Matthew Grounds, his former UBS colleague Guy Fowler, and Sydney businessman Gary Weiss.

This year’s conference is expected to bring the total funds raised for medical research by the Sohn conferences in Australia to more than $70m since the first conference in November 2016.

Bannan started her career at accounting firm KPMG, where she gained her accounting qualifications, before moving to the sell side sector with a job at Macquarie Bank. “Then the opportunity came up to move into the small-caps team at IFM and I have been here ever since,” she said.

With a history dating back to 1990, the former Industry Funds Management (now known as IFM Investors) was founded by some of the country’s largest industry super funds. Now owned by 17 major Australian super funds, it has expanded globally and now manages money for more than 660 institutions including insurance companies, universities and sovereign wealth funds.

This year’s Sohn Hearts & Minds conference will be hosted at Adelaide’s Festival Theatre on Friday, November 15. Themes for the 2024 event include space, artificial intelligence, geopolitics, biosciences and investing.

The conference includes stock picks from leading investment experts all over the globe, and is held this year in partnership with the South Australian government.

Half of the proceeds will go to the SA Health and Medical Research Institute.

The Australian is a media partner of the conference. 

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

While the performance of the small cap sector in Australia has been mixed in recent years, IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks in Australia, including in the consumer sector.

“It’s been a tough couple of years for small caps, but this might be the year for them,” said Bannan, a small cap specialist at the $220bn industry super backed IFM Investors.

“Mispriced opportunities tend to be more prevalent in the small cap sector. It could be a good time to be investing in the space.”

Bannan, whose stock tip at the last Sohn Australia conference last November – ASX-listed bio tech company Telix Pharmaceuticals – has more than doubled in price over the year, will be tipping another small cap when she speaks at this year’s Sohn conference in Adelaide on November 15.

But with Sohn attendees paying $3500 a head for tickets to the conference, she is tight-lipped about what sector it might be in.

There are some hints she likes some stocks in the consumer sector, with some companies performing better than expected and this year’s tax rate cuts and expected falls in interest rates over the next year ease pressure on consumers.

“The consumer sector – whether it is retail, consumer services, media, or travel – has been quite topical recently,” she said.

“It has been a tough consumer environment in the last couple of years given the cost-of-living pressures and high interest rates.

“(But) a lot of stocks have performed better than expected and declines in same-store sales have not been as severe.”

Bannan says some retailers have done a good job managing their costs, including managing inventory, “which means gross margins have held up well”.

“With the focus turning to rate cuts and the tax cuts which kicked in in June, there is a sense that the consumer could be through the worst of it,” she said.

“It is still a tough environment, but … there could be potentially some good opportunities there.”

IFM, which has $65bn in shares, manages funds for industry super funds in Australia as well as institutional investors offshore, and does not publish a list of its holdings.

Bannan says IFM’s small cap holdings range from companies in mining, health care and tech to the consumer sector. But even within sectors, she says, there are very different companies with very different growth potential.

“Across any sector we are looking for the structural growth story,” she said. “We are very bottom up focused.

IFM prefers companies that can grow despite the prevailing macro economic conditions, she adds. “We are looking for businesses with a sustainable competitive advantage. There is a big focus on the quality of management, understanding their strategy and how they are going to execute it, how they plan to fund it.

“We look at the cash generation of the business.”

Bannan says IFM also has a strong interest in “founder-led businesses”. “We like management to be aligned with shareholders.”

While Bannan is still a fan of Telix, which she believes still has significant potential in the growing area of cancer diagnostics, she will be tipping a very different stock this year. She has a strong interest in healthcare stocks and is on the advisory committee of HEAL Partners, a growth private equity fund focused on investments within the health, education and lifestyle sectors.

Bannan says she has had an interest in supporting the Sohn conference which raises money for medical research as one of her closest friends died of cancer at the age of 34. She jumped at the chance to participate in the conference last year and the success of her stock pick in 2023 has seen her invited back again.

Co-founders of the conference in Australia have included former UBS chief Matthew Grounds, his former UBS colleague Guy Fowler, and Sydney businessman Gary Weiss.

This year’s conference is expected to bring the total funds raised for medical research by the Sohn conferences in Australia to more than $70m since the first conference in November 2016.

Bannan started her career at accounting firm KPMG, where she gained her accounting qualifications, before moving to the sell side sector with a job at Macquarie Bank. “Then the opportunity came up to move into the small-caps team at IFM and I have been here ever since,” she said.

With a history dating back to 1990, the former Industry Funds Management (now known as IFM Investors) was founded by some of the country’s largest industry super funds. Now owned by 17 major Australian super funds, it has expanded globally and now manages money for more than 660 institutions including insurance companies, universities and sovereign wealth funds.

This year’s Sohn Hearts & Minds conference will be hosted at Adelaide’s Festival Theatre on Friday, November 15. Themes for the 2024 event include space, artificial intelligence, geopolitics, biosciences and investing.

The conference includes stock picks from leading investment experts all over the globe, and is held this year in partnership with the South Australian government.

Half of the proceeds will go to the SA Health and Medical Research Institute.

The Australian is a media partner of the conference. 

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Oct 27, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November 16, 2023

The ‘Armageddon Scenario’ Worrying The Future Fund CIO

Mr Samild shared his thoughts on the bond market – which underpins the returns of other assets – ahead of his appearance at Friday’s Sohn Hearts & Minds charity conference at the Sydney Opera House.

Read More
Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.
November 15, 2023

Advancing Medicine Is In Daniel MacArthur’s DNA

When genomic scientist Daniel MacArthur had the opportunity to set up a new Centre for Population Genomics in Australia in 2019, he jumped at the chance to return home after 12 years living overseas.

Read More
November 15, 2023

Ashish Swarup - Invest In Snacks, Let's Get That Bread | Aikya Investment Management

Ashish Swarup, Portfolio Manager and Investment Analyst of Aikya Investment Management joins Bryce and Ren to discuss emerging markets, and two stock deep dives.

Read More
Surging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFP
November 15, 2023

Daniel Loeb’s Wall St Hedge Fund Third Point Raises Bets On Corporate Credit Crunch

An “obsession” around balance sheet strength and debt is creating a new wave of investment bets for the influential Wall Street hedge fund run by Daniel Loeb.

Read More
November 13, 2023

Bond Bullish On Commodity Stocks, Uranium

Mining stocks are poised to rise amid tight supply for key commodities such as copper, nickel and uranium, says Terra Capital founder Jeremy Bond.

Read More
November 13, 2023

This Hedge Fund Manager Is Making A 100-Year Bet On Luxury

European leisure and luxury – a designer handbag, a last-minute flight to Monte Carlo, a stay in a five-star hotel – is where many choose to spend their hard-earned cash. For Sharif el Khazen, it’s where he makes it.

Read More
Munro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki Connolly
November 12, 2023

How Munro Will Pick Its Next Stock Winner

Munro partner and portfolio manager Kieran Moore must select a single company to pitch to an audience of industry heavyweights at the prestigious Sohn Hearts & Minds conference in Sydney.

Read More
Ray Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: Bloomberg
November 12, 2023

The Australian At The Centre Of Dalio’s Bridgewater – Who Loves It

The culture at Ray Dalio’s massive hedge fund has been a source of intrigue, and with a new book, controversy. Atul Lele says it’s made him a better investor.

Read More
Sheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic Lorrimer
November 10, 2023

Meet The Goldman Sachs Legend Shaking Up Venture Capital

Sheila Patel says it was time for the venture capital sector to “grow up” and higher rates will help do that job. VC firms need to think differently about how they invest.

Read More
November 8, 2023

Tom Naughton - There's Money In Mi Goreng | Prusik Investment

Tom Naughton is Managing Partner and CIO at Prusik Investment. In this episode, he chats to Equity Mates ahead of his appearance at the 2023 Sohn Hearts and Minds Conference.

Read More
November 6, 2023

Why Chris Kourtis just bought CSL and ResMed

A true contrarian investor, Chris Kourtis can find himself sounding a lot like a bull when in the company of bears, and there’s a lot to be bearish about at the moment.

Read More
Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.
November 5, 2023

Five Secrets To Delivering The Perfect Pitch

Australia’s best stock pickers have just eight minutes to convince the country’s top money managers they have found an investment gem that the market has overlooked.

Read More
Picture: Solomon Lew & David ParadicePicture: Solomon Lew & David ParadicePicture: Solomon Lew & David ParadicePicture: Solomon Lew & David Paradice
November 3, 2023

Paradice and Lew on their love of medical research – and Greece

Solomon Lew, the billionaire retailer, has known David Paradice, the high-profile fund managers, for years. Beyond investing, they share a common interest in medical research – and holidaying in Greece.

Read More
November 2, 2023

Meet the 2023 Conference Managers

Following a rigorous global search, the Conference Fund Manager Selection Committee is pleased to share ten new managers for 2023.

Read More
Daniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: Bloomberg
October 23, 2023

Dan Loeb to headline Sohn Hearts & Minds

Famed hedge fund manager Dan Loeb has been named as one of the headline acts for next month’s Sohn Hearts & Minds philanthropic investment conference to be held in Sydney.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.